StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Ceded Medical Claims Payable by Quarter

Ceded Medical Claims Payable (Reinsurance Recoverable) ($M)

QuarterlyAnnual

Elevance Health Ceded Medical Claims Payable: $45M in Q3 2026, up 2.3% from a year earlier.

Latest, Q3 2026
45
Period ended Sep 30, 2026
Change on a year earlier
+2.3%
44 in Q3 2025
History
38 quarters
Since Q4 2015
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments (2026-09-30): 45,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCeded Medical Claims Payable (Reinsurance Recoverable) ($M)Year on yearSource
Q3 2026Sep 30, 202645+2.3%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q2 2026Jun 30, 202644+175.0%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q1 2026Mar 31, 202645+221.4%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q4 2025Dec 31, 202548+269.2%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q3 2025Sep 30, 202544+388.9%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q2 2025Jun 30, 202516+33.3%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q1 2025Mar 31, 202514+75.0%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q4 2024Dec 31, 202413+85.7%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q3 2024Sep 30, 20249+125.0%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q2 2024Jun 30, 202412+50.0%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q1 2024Mar 31, 20248+14.3%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q4 2023Dec 31, 20237+16.7%ELV 10-K (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q3 2023Sep 30, 20234+33.3%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q2 2023Jun 30, 20238-38.5%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q1 2023Mar 31, 20237-58.8%ELV 10-Q (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗
Q4 2022Dec 31, 20226-71.4%ELV 10-K (XBRL us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments) ↗

Cite this data

StockData. (2026). Elevance Health Ceded Medical Claims Payable ($M), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/mcp-ceded-ending

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.